PPH vs. IXJ: A Pure Pharma Bet Against the Entire Global Healthcare Ecosystem

4 hours ago 2

The VanEck Pharmaceutical ETF (NASDAQ:PPH) provides targeted vulnerability to cause manufacturers, portion the iShares Global Healthcare ETF (NYSEMKT:IXJ) offers a broader scope crossed the planetary aesculapian manufacture including biotechnology and equipment.

Investors looking for healthcare vulnerability often take betwixt niche manufacture funds and wide assemblage trackers. This examination looks astatine however PPH targets the pharmaceutical sub-sector versus however IXJ captures a wider array of aesculapian companies crossed planetary markets.

Snapshot (cost & size)

Metric

PPH

IXJ

Issuer

VanEck

iShares

Expense ratio

0.36%

0.40%

1-yr instrumentality (as of May 20, 2026)

20.40%

10.00%

Dividend yield

2.10%

1.50%

Beta

0.46

0.58

AUM

$915.6 million

$3.6 billion

Beta measures terms volatility comparative to the S&P 500; beta is calculated from five-year monthly returns. The 1-yr instrumentality represents full instrumentality implicit the trailing 12 months. Dividend output is the trailing-12-month organisation yield.

The VanEck money is somewhat much affordable with a 0.36% disbursal ratio compared to 0.40% for the iShares fund. Additionally, the VanEck money provided a higher payout implicit the past year, yielding 2.10% compared to 1.50% for IXJ.

Performance & hazard examination

Metric

PPH

IXJ

Max drawdown (5 yr)

(20.30%)

(18.10%)

Growth of $1,000 implicit 5 years (total return)

$1,544

$1,220

What's wrong

The iShares Global Healthcare ETF offers wide assemblage coverage, with healthcare astatine 99%. It holds 114 positions and was launched successful 2001. Its largest positions see Eli Lilly (NYSE:LLY) astatine 10.50%, Johnson & Johnson (NYSE:JNJ) astatine 7.19%, and Abbvie (NYSE:ABBV) astatine 4.88%. Over the trailing 12 months, the iShares money paid $1.36 per stock successful dividends.

The VanEck Pharmaceutical ETF is simply a pure-play enactment with 100% healthcare vulnerability focused connected the MVIS US Listed Pharmaceutical 25 Index. It holds 26 positions and was launched successful 2011. Its apical holdings see Eli Lilly & Co astatine 21.01%, Novartis (NYSE:NVS) astatine 10.76%, and Merck & Co (NYSE:MRK) astatine 9.23%. Over the trailing 12 months, the VanEck money paid $2.15 per stock successful dividends.

For much guidance connected ETF investing, cheque retired the afloat usher astatine this link.

What this means for investors

For diligent investors, healthcare tin beryllium 1 of the astir compelling semipermanent concern themes successful your portfolio. An aging planetary population, breakthrough cause development, and expanding aesculapian exertion make structural tailwinds that fewer different sectors tin match. But the risks are real, too. You’re dealing with cause patent cliffs, regulatory uncertainty, and authorities pricing pressure, which tin measurement connected adjacent the strongest companies.

Read Entire Article